Mr. Greg Engel of Organigram reports
ORGANIGRAM SIGNS STRATEGIC SUPPLIER AGREEMENT WITH HIKU BRANDS
Organigram Holdings Inc. has entered into a letter of intent (LOI) with Hiku Brands Company Ltd.
As an approved supplier to Manitoba Liquor & Lotteries (MBLL), Organigram will supply Hiku with up to 1,000 kilograms of premium cannabis products per year for the term of the three-year agreement. Products include both dried cannabis and cannabis oils, which will be sold through designated Tokyo Smoke retail locations in Manitoba.
"Organigram and Hiku share a deep commitment to exceptional quality and innovative products," said Greg Engel, chief executive officer, Organigram. "As we move towards a legal, adult-recreational-use cannabis market, we are proud to be affiliated with companies and brands with a clear and demonstrated focus on their customers and a first-class customer experience."
The relationship is based on several discussions between the groups on product portfolio, strategic direction, quality and branding. A selection of brands, featuring Organigram's 2017 Canadian cannabis award-winning sativa Wabanaki, will be chosen to play a role in Tokyo Smoke's retail plans within the Manitoba market.
"Hiku is excited to have the opportunity to carry Organigram's products in Tokyo Smoke stores," said Alan Gertner, chief executive officer of Hiku Brands. "This agreement will help ensure additional quality indoor-grown cannabis is available to the adult-use consumer in the province of Manitoba, where Tokyo Smoke was awarded one of only four conditional master licences for recreational storefronts allowing us to open multiple storefronts across the province."
About Organigram Holdings Inc.
Organigram Holdings is a TSX Venture Exchange-listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest-quality, condition-specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, N.B., and the company is regulated by the Access to Cannabis for Medical Purposes Regulations.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.